Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the DPP IV Inhibitors (DPP-4 Inhibitors) industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Mitsubishi Tanabe Pharma
Takeda
Merck
AstraZeneca
Novartis
Eli Lilly
By Type:
Sitagliptin
Linagliptin
Vildagliptin
Others
Saxagliptin
By Application:
Retail Pharmacies
Hospital
Online Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Overview 2018-2029
-
1.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Industry Development Overview
-
1.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Industry Development History
-
1.3 China DPP IV Inhibitors (DPP-4 Inhibitors) Industry Market Size (2018-2029)
-
1.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis by Type from Production Side
-
1.4.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Sitagliptin (2018-2029)
-
1.4.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Linagliptin (2018-2029)
-
1.4.3 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Vildagliptin (2018-2029)
-
1.4.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.5 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Saxagliptin (2018-2029)
-
1.5 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis by Application from Consumption End
-
1.5.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.3 China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.6 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis by Region
-
1.6.1 North China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
1.6.3 South China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
1.6.4 East China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
Chapter 2 China DPP IV Inhibitors (DPP-4 Inhibitors) Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on DPP IV Inhibitors (DPP-4 Inhibitors) Market Status and Competition at home and abroad in 2023
-
2.2.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Status and Competition Analysis in 2023
-
2.2.3 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China DPP IV Inhibitors (DPP-4 Inhibitors) Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on DPP IV Inhibitors (DPP-4 Inhibitors) Industry Development
Chapter 3 DPP IV Inhibitors (DPP-4 Inhibitors)Industry Chain Analysis
-
3.1 DPP IV Inhibitors (DPP-4 Inhibitors) Industry Chain
-
3.2 DPP IV Inhibitors (DPP-4 Inhibitors) Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the DPP IV Inhibitors (DPP-4 Inhibitors) Market
-
3.3 DPP IV Inhibitors (DPP-4 Inhibitors) Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the DPP IV Inhibitors (DPP-4 Inhibitors) Market
Chapter 4 China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
4.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Total Production Volume and Growth Rate from Production Side
-
4.5 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate, by Type
-
4.5.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Sitagliptin
-
4.5.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Linagliptin
-
4.5.3 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Vildagliptin
-
4.5.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Others
-
4.5.5 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Saxagliptin
Chapter 5 China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China DPP IV Inhibitors (DPP-4 Inhibitors) Total Market Size and Growth Rate from Consumption End
-
5.5 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate, by Application
-
5.5.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate of Retail Pharmacies
-
5.5.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate of Hospital
-
5.5.3 China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate of Online Pharmacies
Chapter 6 China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Region
-
6.1 China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Production Value, by Region
-
6.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume and Sales Value, by Region
Chapter 7 North China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
7.1 North China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
7.2 North China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 8 Central China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
8.1 Central China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
8.2 Central China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 9 South China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
9.1 South China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
9.2 South China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 10 East China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
10.1 East China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
10.2 East China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 11 Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
11.1 Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
11.2 Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 12 Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
12.1 Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
12.2 Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 13 Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis
-
13.1 Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Type
-
13.2 Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market, by Application
Chapter 14 Company Profiles
-
14.1 Mitsubishi Tanabe Pharma
-
14.1.1 Mitsubishi Tanabe Pharma Company Profile
-
14.1.2 Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Takeda
-
14.2.1 Takeda Company Profile
-
14.2.2 Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Merck
-
14.3.1 Merck Company Profile
-
14.3.2 Merck DPP IV Inhibitors (DPP-4 Inhibitors) Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Profile
-
14.4.2 AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile
-
14.5.2 Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Profile
-
14.6.2 Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 DPP IV Inhibitors (DPP-4 Inhibitors) Industry Research Conclusions
-
15.2 DPP IV Inhibitors (DPP-4 Inhibitors) Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Industry Market Size (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Sitagliptin (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Linagliptin (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Vildagliptin (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume, Production Value and Growth Rate of Saxagliptin (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure North China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure Central China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure South China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure East China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate from 2018-2029
-
Figure DPP IV Inhibitors (DPP-4 Inhibitors) Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2018
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2023
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Sitagliptin (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Linagliptin (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Vildagliptin (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Others (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume and Growth Rate of Saxagliptin (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2018
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2023
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Total Market Size and Growth Rate from Consumption End
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Region (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Production Value by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Production Value Share by Region (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Production Value Share by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Region (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Value by Region (2018-2023)
-
Table China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Value Share by Region (2018-2023)
-
Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Value Share by Region (2018-2023)
-
Table North China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table North China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure North China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table North China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table North China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure North China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table Central China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table Central China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure Central China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table Central China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table Central China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure Central China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table South China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table South China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure South China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table South China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table South China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure South China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table East China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table East China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure East China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table East China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table East China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure East China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure Northeast China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure Southwest China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume by Type (2018-2023)
-
Table Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Figure Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Production Volume Share by Type (2018-2023)
-
Table Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume by Application (2018-2023)
-
Table Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Figure Northwest China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Volume Share by Application (2018-2023)
-
Table Mitsubishi Tanabe Pharma Company Profile
-
Table Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck DPP IV Inhibitors (DPP-4 Inhibitors) Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Revenue, Price and Gross (2018-2023)
-
